Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-253-3 | CAS number: 13709-42-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
ACUTE TOXICITY: VIA THE ORAL ROUTE
All three studies report an acute oral LD50 in the rat of >5000 mg/kg bodyweight.
ACUTE TOXICITY: VIA INHALATION ROUTE
In accordance with Section 2 of Annex XI of Regulation (EC) No. 1907/2006, the acute toxicity by inhalation study, listed under point 8.5.2 of Annex VIII of the same Regulation, had been waived as it is not technically feasible to conduct the study. The sticky nature of the test substance made it impossible to generate the dust atmosphere required for the study.
ACUTE TOXICITY: VIA DERMAL ROUTE
The dermal LD0 in the rat was >2000 mg/kg.
ACUTE TOXICITY: OTHER ROUTES
the LD0 of the test material to the rat is >5000 mg/kg when administered via the intraperitoneal route.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- not reported
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted to GLP in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Strain: Sprague-Dawley OFA (IOPS)
- Age at study initiation: 6 - 7 weeks
- Weight at study initiation (prior to fasting): 160 - 200 g (males); 140 - 180 g (females)
- Fasting period before study: yes (17 hours)
- Housing: 2 or 5 animals in plastic cages (365 x 225 x 180 mm) containing a sterilised and vacuum-cleaned sawdust litter
- Food consumption: ad libitum
- Water consumption: ad libitum
- Acclimation period: data not available
ENVIRONMENTAL CONDITIONS:
- Temperature: 22 ± 1.5 °C
- Humidity: 55 ± 15 %
- Air changes: 10 per hour
- Photoperiod: data not available - Route of administration:
- oral: gavage
- Vehicle:
- other: 10 % aqueous dispersion of gum arabic
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 50 g test item / 100 mL
- Amount of vehicle (if gavage): 10 mL/kg
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw - Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 5 animals per sex per dose.
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
> behaviour and mortality: 1, 2 and 4 h, and on days 1, 2, 4, 7 and 14 after treatment
> weighing: one day before treatment, and on days 0, 7 and 14 after treatment
- Necropsy of survivors performed: yes - Preliminary study:
- Mortality checks were performed at 1, 2, 4 hours, and then on days 1, 2, 4, 7 and 14.
No mortality was observed. - Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was observed in rats dosed with 0 or 5000 mg/kg bw.
- Clinical signs:
- other: No clinical signs were observed.
- Gross pathology:
- No gross abnormalities were observed at necropsy.
- Other findings:
- No mortality in preliminary test
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The oral LD0 (males and females) was >5000 mg/kg bw and therefore the test material is not classified for acute oral toxicity based on the results of this study in accordance with EU criteria.
- Executive summary:
An acute oral toxicity limit test was conducted to assess the test material in accordance with the standardised guidelines OECD 401 and EU Method B.1.
Groups of fasted, 6 - 7 week old Sprague-Dawley rats (5 per sex) were given a single oral dose of the test material in a 10 % aqueous solution of gum arabic at a dose of 5000 mg/kg bw and observed for 14 days. 5 animals were dosed with the vehicle only.
No mortality and no clinical signs were observed during the study. No gross abnormalities were observed at necropsy.
The oral LD0 (males and females) was >5000 mg/kg bw and therefore the test material is not classified for acute oral toxicity based on the results of this study in accordance with EU criteria.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- Two supporting studies are available. The first was conducted in accordance with the standardised FHSA guideline 16 CFR 1500.3. It was well reported and adhered to sound scientific principles. It was awarded a reliability score of 1 in accordance with the criteria of Klimisch (1997).
The second supporting study was conducted in accordance with a method which was broadly equivalent to the standardised FHSA guideline 16 CFR 1500.3. It adhered to sound scientific principles, however was not fully reported and as such was awarded a reliability score of 2 in accordance with the criteria of Klimisch (1997).
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- not reported
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted to GLP in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Strain: Sprague-Dawley OFA (IOPS)
- Age at study initiation: 6 - 7 weeks
- Weight at study initiation (prior to fasting): 160 - 200 g (males); 140 - 180 g (females)
- Fasting period before study: no
- Housing: animals were individually housed in plastic cages (375 x 170 x 150 mm) containing a sterilised and vacuum-cleaned sawdust litter
- Food consumption: ad libitum
- Water consumption: ad libitum
- Acclimation period: data not available
ENVIRONMENTAL CONDITIONS:
- Temperature: 22 ± 1.5 °C
- Humidity: 55 ± 15 %
- Air changes: 10 per hour
- Photoperiod: data not available - Type of coverage:
- occlusive
- Vehicle:
- other: 10 % aqueous dispersion of gum arabic
- Details on dermal exposure:
- -The test material was applied to the shaved laterodorsal area of the back. It was administered in the 10 % aqueous dispersion of gum Arabic at a dose volume of 5 mL/kg and a concentration of 40 g/mL.
-The test material was covered by foil and secured with tape.
-After 24 hours, the dressing was removed and the treated area rinsed with warm water. - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5 animals per sex per dose
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
> behaviour and mortality: after application, then 1, 2 and 4 hours; daily from day 1 to day 14
> weighing: one day before treatment, and on days 0, 7 and 14 after treatment
>cutaneous condition was noted from day 1 onwards
- Necropsy of survivors performed: yes - Preliminary study:
- Mortality checks were performed at 1, 2, 4 hours, and then on days 1, 2, 4, 7 and 14.
No mortality was observed. - Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was observed.
- Clinical signs:
- other: No abnormalities, erythema or oedema were observed.
- Gross pathology:
- No gross abnormalities were observed at necropsy.
- Other findings:
- No mortalities in the preliminary test.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The dermal LD0 (males and females) was >2000 mg/kg bw and therefore the test material is not classified based on the results of this study in accordance with EU criteria.
- Executive summary:
An acute dermal toxicity limit test was conducted to assess the test material in accordance with the standardised guidelines OECD 402 and EU Method B.3.
Groups of 6 - 7 week old Sprague-Dawley rats (5 per sex) were exposed to a single 2000 mg/kg dermal dose of the test material in a 10 % aqueous solution of gum arabic. The test material was applied to the shaved laterodorsal area and the site covered in foil secured with tape. After 24 hours, the dressing was removed and the site rinsed with water. Animals were observed for 14 days.
No mortality and no clinical signs were observed during the study. No gross abnormalities were observed at necropsy.
The dermal LD0 (males and females) was >2000 mg/kg and therefore the test material is not classified for acute dermal toxicity based on the results of this study in accordance with EU criteria.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- The key study was conducted in line with GLP and in accordance with the standardised guidelines OECD 402 and EU method B.3. It was well reported and adhered to sound scientific principles. It was awarded a reliability score of 1 in accordance with the criteria of Klimisch (1997).
Additional information
Acute toxicity: via the oral route
The key study is an acute oral toxicity limit test conducted in accordance with the standardised guidelines OECD 401 and EU Method B.1.
Groups of fasted, 6 - 7 week old Sprague-Dawley rats (5 per sex) were given a single oral dose of the test material in a 10 % aqueous solution of gum arabic at a dose of 5000 mg/kg bw and observed for 14 days. 5 animals were dosed with the vehicle only.
No mortality and no clinical signs were observed during the study. No gross abnormalities were observed at necropsy.
The oral LD0 (males and females) was >5000 mg/kg bw and therefore the test material is not classified for acute oral toxicity based on the results of this study in accordance with EU criteria.
The first supporting study is an acute oral toxicity limit test conducted in accordance with FHSA guideline 16 CFR 1500.3.
Groups of fasted Sprague-Dawley rats (5 per sex) were given a single oral dose of the test material in certified feed at a dose of 5000 mg/kg bw and observed for 14 days.
The oral LD50 (males and females) was > 5000 mg/kg bw and therefore the substance is not classified for acute oral toxicity according to EU criteria on the basis of this study.
The second supporting study is an acute oral toxicity limit test was conducted broadly in accordance with FHSA guideline 16 CFR 1500.3.
Groups of fasted Sprague-Dawley rats (5 per sex) were given a single oral dose of the test material in distilled water at a dose of 5000 mg/kg as a 50 % w/w solution and observed for 14 days.
The oral LD50 (males and females) was > 5000 mg/kg bw and therefore the material is not classified for acute oral toxicity according to EU criteria on the basis of this study.
Acute toxicity: via the inhalation route
In the supporting study, an attempt was made to assess the toxicity potential of the test material via the inhalation route in accordance with the standardised guideline OECD 436.
Due to the nature of the test material, the study was not carried out due to a lack of success at creating a suitable exposure atmosphere for animals. It was not possible to generate an atmosphere of the test material that was suitable for an acute inhalation study, either as a dust or liquid aerosol.
It may have been possible to generate an atmosphere by dissolving the test material in a suitable solvent, but this was ultimately considered to be unrepresentative of the hazard presented by the test material and so was not pursued further.
In view of the physical nature of the test material and its apparent low volatility, it is considered unlikely to represent a significant hazard by the inhalation route in its original form.
Acute toxicity: via the dermal route
An acute dermal toxicity limit test was conducted to assess the test material in accordance with the standardised guidelines OECD 402 and EU Method B.3.
Groups of 6 - 7 week old Sprague-Dawley rats (5 per sex) were exposed to a single 2000 mg/kg dermal dose of the test material in a 10 % aqueous solution of gum arabic. The test material was applied to the shaved laterodorsal area and the site covered in foil secured with tape. After 24 hours, the dressing was removed and the site rinsed with water. Animals were observed for 14 days.
No mortality and no clinical signs were observed during the study. No gross abnormalities were observed at necropsy.
The dermal LD0 (males and females) was >2000 mg/kg and therefore the test material is not classified for acute dermal toxicity based on the results of this study in accordance with EU criteria.
Acute toxicity: via other routes
A supporting study is provided in which the toxicity of the test material when administered by the intraperitoneal route was investigated.
No guideline was available for this type of study, however it was carried out in accordance with sound scientific methodology and the principles of good laboratory practice. As such it was awarded a reliability score of 2 in accordance with the criteria of Klimisch (1997).
10 fasted Sprague-Dawley rats (5 per sex) were administered the test material via the intraperitoneal route in a 10 % aqueous dispersion of gum arabic. The animals were observed for 14 days before being euthanised and subject to necropsy.
There was no mortality seen and no abnormal effects on bodyweight were reported. Clinical signs observed were hollow flanks in some animals, while others were observed to have bloated bellies.
During the postmortem examinations, the abdominal and chest cavities were opened and the organs inspected. It was noted that the test material was present with granulomas.
Under the conditions of this study, the LD0 of the test material to the Sprague-Dawley rat is >5000 mg/kg when administered via the intraperitoneal route in a 10 % aqueous dispersion of gum arabic.
Justification for selection of acute toxicity – oral endpoint
The key study was conducted in line with GLP and in accordance with the standardised guidelines OECD 401 and EU Method B.1. It was well reported and adhered to sound scientific principles. It was awarded a reliability score of 1 in accordance with the criteria of Klimisch (1997).
Justification for selection of acute toxicity – dermal endpoint
Only one study available.
Justification for classification or non-classification
In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No. 1272/2008, the test material does not require classification for acute toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.